Monash IVF Revises FY25 Underlying NPAT Guidance To A$27.5 Mln

Published on 20/05/2025 at 11:26

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Monash IVF Group Limited

Monash IVF Group Appoints Interim Chief Financial Officer	16/07	MT
Monash IVF Group appoints Andrew MacLachlan as interim CFO	16/07	RE
Monash IVF Group Discloses Interim Remuneration Package for Acting CEO	03/07	MT
Monash IVF Says Challenger Ceases to Be a Substantial Holder	13/06	MT
Australia's Monash IVF CEO quits days after second embryo mix-up in 2 months	12/06	RE
Australian Shares Inch Down Amid Trump's Tariff Plans; Monash IVF Group CEO Resigns After Second Embryo Error	12/06	MT
Monash IVF Group Limited Announces CEO Changes	12/06	CI
Monash IVF Group Limited Announces Resignation of Michael Knaap as Managing Director and Director	12/06	CI
Monash IVF Group CEO Michael Knaap Resigns After Second Embryo Error	12/06	MT
Monash IVF Group Says CEO Michael Knaap Resigns	12/06	RE
Michael Knaap resigns as CEO of Australia's Monash IVF	12/06	RE
Monash IVF Recovers From Embryo Transfer Mix-Up-Related Slump; Shares Up 15%	11/06	MT
Australian Shares Rise as US-China Trade Talks Extend;Rio Tinto Seeks Billions to Save New South Wales Smelter From Closing	10/06	MT
Monash IVF Group on Higher Reputational Damage Risk After Second IVF Mistake, Says RBC, The Australian Reports	10/06	MT
A second Australian IVF mix-up shakes clinic and industry	10/06	RE
A second Australian IVF mix-up shakes clinic and industry	10/06	RE
Monash IVF Confirms Embryo Transfer Mix-Up at Clayton Lab; Shares Hit Five-Year Low	10/06	MT
Australia's Monash IVF reports second embryo incident in two months	10/06	RE
Australia's Monash IVF looking into error in embryo transfer at laboratory	10/06	RE
Monash IVF Group Reports Embryo Transfer Incident At Clayton Lab	10/06	RE
Monash IVF Revises FY25 Underlying NPAT Guidance To A$27.5 Mln	20/05	RE
Monash IVF Group Cuts Fiscal 2025 Profit Guidance to About AU$27.5 Million	20/05	MT
Monash IVF Says Brisbane Clinic Incident Not Expected to Impact Share Price; Shares Rise 7%	23/04	MT
Ord Minnett Upgrades Monash IVF Group to Buy from Hold, Price Target is AU$1.10	18/04	MT
Morgans Financial Downgrades Monash IVF Group to Hold From Add; Price Target is AU$1.09	11/04	MT